Trial · NCT02075255
Adverse events117
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 117
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Vertigo | Ear and labyrinth disorders | Benra 30 mg q.4 Weeks | 1 | 72 | 5 |
| other | Vertigo | Ear and labyrinth disorders | Benra 30 mg q.8 Weeks | 3 | 73 | 3 |
| other | Vertigo | Ear and labyrinth disorders | Placebo | 2 | 75 | 2 |
| other | Nausea | Gastrointestinal disorders | Benra 30 mg q.4 Weeks | 1 | 72 | 1 |
| other | Nausea | Gastrointestinal disorders | Benra 30 mg q.8 Weeks | 0 | 73 | 0 |
| other | Nausea | Gastrointestinal disorders | Placebo | 3 | 75 | 3 |
| other | Bronchitis | Infections and infestations | Benra 30 mg q.4 Weeks | 5 | 72 | 7 |
| other | Bronchitis | Infections and infestations | Benra 30 mg q.8 Weeks | 8 | 73 | 10 |
| other | Bronchitis | Infections and infestations | Placebo | 12 | 75 | 13 |
| other | Influenza | Infections and infestations | Benra 30 mg q.4 Weeks | 3 | 72 | 3 |
| other | Influenza | Infections and infestations | Benra 30 mg q.8 Weeks | 1 | 73 | 1 |
| other | Influenza | Infections and infestations | Placebo | 5 | 75 | 5 |
| other | Nasopharyngitis | Infections and infestations | Benra 30 mg q.4 Weeks | 11 | 72 | 13 |
| other | Nasopharyngitis | Infections and infestations | Benra 30 mg q.8 Weeks | 12 | 73 | 14 |
| other | Nasopharyngitis | Infections and infestations | Placebo | 15 | 75 | 17 |
| other | Oral candidiasis | Infections and infestations | Benra 30 mg q.4 Weeks | 0 | 72 | 0 |
| other | Oral candidiasis | Infections and infestations | Benra 30 mg q.8 Weeks | 0 | 73 | 0 |
| other | Oral candidiasis | Infections and infestations | Placebo | 4 | 75 | 4 |
| other | Rhinitis | Infections and infestations | Benra 30 mg q.4 Weeks | 2 | 72 | 2 |
| other | Rhinitis | Infections and infestations | Benra 30 mg q.8 Weeks | 6 | 73 | 7 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02075255/events